Tetra Bio-Pharma Inc.
TBP
Rangering i aksjer
#35389
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Aksjekurs
$0.01851783
Sist synkronisert: 2023-05-23
Markedsverdi
$3.71M
Endring (1 dag)
-0.04%
Endring (1 år)
1,443.15%
Land
CA
Handel Tetra Bio-Pharma Inc. (TBP)
Kategori
Healthcare
Aksjeprishistorikk for Tetra Bio-Pharma Inc. (TBP)
Høyeste sluttskurs: $0.00 den 2023-10-01
Laveste sluttskurs: $0.28 den 2011-07-01
Laveste sluttskurs: $0.28 den 2011-07-01
Aksjeprishistorikk for Tetra Bio-Pharma Inc. fra 2011 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2023 | -95.84% |
| 2022 | -82.62% |
| 2021 | -21.66% |
| 2020 | -60.26% |
| 2019 | -40.62% |
| 2018 | -5.58% |
| 2017 | 216.26% |
| 2016 | 899.04% |
| 2015 | -56.08% |
| 2014 | 17.07% |
| 2013 | 0.00% |
| 2012 | -69.35% |
| 2011 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.89 | -3.74% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
